Summit Therapeutics, Inc. (SMMT)
16.81
-0.23
(-1.35%)
USD |
NASDAQ |
Jan 13, 16:00
16.89
+0.08
(+0.48%)
After-Hours: 20:00
Summit Therapeutics Market Cap: 12.51B for Jan. 13, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Insmed, Inc. | 34.92B |
| Madrigal Pharmaceuticals, Inc. | 11.22B |
| CorMedix, Inc. | 557.43M |
| Travere Therapeutics, Inc. | 2.606B |
| Viridian Therapeutics, Inc. | 3.053B |
Market Cap Related Metrics
| PEG Ratio | -0.0388 |
| Price to Book Value | 65.09 |
| Price | 16.81 |
| Earnings Yield | -7.39% |
| PEGY Ratio | -0.0388 |